Amplification of c-MET in Malignant Mesothelioma

被引:0
|
作者
Fedeli, Franco
Varesano, Serena
Salvi, Sandra
Boccardo, Silmona
Truini, Mauro
Ferro, Paola
Canessa, Pier Aldo
Pistillo, Maria Pia
Roncella, Silvio
机构
[1] ASL5, La Spezia, Italy
[2] IRCCS AOU San Martino IST, Genoa, Italy
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1905
引用
收藏
页码:475A / 476A
页数:2
相关论文
共 50 条
  • [41] Dramatic Response to Cabozantinib in a Patient with Refractory Hepatocellular Carcinoma with c-MET Amplification
    Sang, Yun Beom
    Kim, Gwangil
    Hwang, Sohyun
    Kang, Haeyoun
    Chon, Hong Jae
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (03) : 747 - 750
  • [42] Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma
    Kondo, Shunsuke
    Ojima, Hidenori
    Tsuda, Hitoshi
    Hashimoto, Jun
    Morizane, Chigusa
    Ikeda, Masafumi
    Ueno, Hideki
    Tamura, Kenji
    Shimada, Kazuaki
    Kanai, Yae
    Okusaka, Takuji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (02) : 207 - 213
  • [43] A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene
    Tada, Yuji
    Hiroshima, Kenzo
    Shimada, Hideaki
    Morishita, Naoya
    Shirakawa, Toshiro
    Matsumoto, Kunio
    Shingyoji, Masato
    Sekine, Ikuo
    Tatsumi, Koichiro
    Tagawa, Masatoshi
    SPRINGERPLUS, 2015, 4
  • [44] Inhibition of the HGF/c-Met Pathway for Malignant Mesothelioma with an Intra-Thoracic Injection of the NK4 Expressing Adenoviral Vectors
    Tada, Y.
    Morinaga, T.
    Sekine, I.
    Suzuki, T.
    Shimomura, I.
    Tatsumi, K.
    Takiguchi, Y.
    Shimada, H.
    Hiroshima, K.
    Tagawa, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S756 - S756
  • [45] An exploration of HER2 protein expression and the co-targeting of the c-MET and HER pathway in malignant pleural mesothelioma (MPM)
    Oguh, L.
    Campbell, A.
    Tariq, S.
    Cawkwell, L.
    Lind, M.
    LUNG CANCER, 2018, 115 : S27 - S27
  • [46] Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma
    Edina Tolnay
    Cornelius Kuhnen
    Thorsten Wiethege
    Jens-Eckehard König
    Bruno Voss
    Klaus-Michael Müller
    Journal of Cancer Research and Clinical Oncology, 1998, 124 : 291 - 296
  • [47] Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma
    Shunsuke Kondo
    Hidenori Ojima
    Hitoshi Tsuda
    Jun Hashimoto
    Chigusa Morizane
    Masafumi Ikeda
    Hideki Ueno
    Kenji Tamura
    Kazuaki Shimada
    Yae Kanai
    Takuji Okusaka
    International Journal of Clinical Oncology, 2013, 18 : 207 - 213
  • [48] FREQUENT AMPLIFICATION OF THE C-MET GENE IN SCIRRHOUS TYPE STOMACH-CANCER
    KUNIYASU, H
    YASUI, W
    KITADAI, Y
    YOKOZAKI, H
    ITO, H
    TAHARA, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (01) : 227 - 232
  • [49] Hepatocyte growth factor scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma
    Tolnay, E
    Kuhnen, C
    Wiethege, T
    Konig, JE
    Voss, B
    Muller, KM
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (06) : 291 - 296
  • [50] Anti-VEGF Therapy Revived by c-Met Inhibition, But Is c-Met the Answer?
    Lynn, Kristi D.
    Brekken, Rolf A.
    CANCER DISCOVERY, 2012, 2 (03) : 211 - 213